Sex-specific predictors of PCSK9 levels in a European population: The IMPROVE study. (2020)
Attributed to:
Understanding the excess risk of cardiometabolic disease in individuals with serious mental illness
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.atherosclerosis.2020.07.014
PubMed Identifier: 32862087
Publication URI: http://europepmc.org/abstract/MED/32862087
Type: Journal Article/Review
Volume: 309
Parent Publication: Atherosclerosis
ISSN: 0021-9150